JMP Securities started coverage on shares of Hinge Health (NYSE:HNGE - Get Free Report) in a research report issued on Monday,Benzinga reports. The brokerage set a "market outperform" rating and a $58.00 price target on the stock. JMP Securities' price target points to a potential upside of 20.36% from the stock's current price.
Other research analysts have also issued reports about the company. Piper Sandler started coverage on Hinge Health in a report on Monday, June 16th. They issued an "overweight" rating and a $41.00 target price for the company. KeyCorp lifted their price objective on Hinge Health from $45.00 to $60.00 and gave the company an "overweight" rating in a research note on Monday. Citizens Jmp began coverage on shares of Hinge Health in a research note on Monday. They set a "mkt outperform" rating and a $58.00 target price on the stock. William Blair initiated coverage on shares of Hinge Health in a report on Monday, June 16th. They issued an "outperform" rating on the stock. Finally, Bank of America began coverage on shares of Hinge Health in a report on Monday, June 16th. They set a "buy" rating and a $42.00 price target for the company. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, Hinge Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $49.36.
Get Our Latest Analysis on HNGE
Hinge Health Trading Up 1.2%
Hinge Health stock traded up $0.55 during mid-day trading on Monday, reaching $48.19. 830,694 shares of the company's stock were exchanged, compared to its average volume of 1,045,669. Hinge Health has a twelve month low of $33.42 and a twelve month high of $52.16.
About Hinge Health
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
Featured Stories

Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.